RCP
Rothschild Capital Partners Portfolio holdings
AUM
$381M
This Quarter Return
+4.86%
1 Year Return
+16.08%
3 Year Return
+77.75%
5 Year Return
+137.62%
10 Year Return
+439.99%
AUM
$222M
AUM Growth
+$222M
(+9.8%)
Cap. Flow
+$28.7M
Cap. Flow
% of AUM
12.93%
Top 10 Holdings %
Top 10 Hldgs %
48.77%
Holding
43
New
3
Increased
9
Reduced
10
Closed
–
Top Buys
| 1 |
APC
Anadarko Petroleum
APC
|
$8.71M |
| 2 |
Amazon
AMZN
|
$2.88M |
| 3 |
SN
Sanchez Energy Corporation
SN
|
$1.83M |
| 4 |
ENOC
EnerNOC, Inc.
ENOC
|
$1.45M |
| 5 |
UPI
UROPLASTY INC-NEW
UPI
|
$487K |
Top Sells
| 1 |
Donaldson
DCI
|
$733K |
| 2 |
Alphabet (Google) Class C
GOOG
|
$15.5K |
| 3 |
Ecolab
ECL
|
$7.24K |
| 4 |
Plains All American Pipeline
PAA
|
$4.8K |
| 5 |
Meta Platforms (Facebook)
META
|
$3.57K |
Sector Composition
| 1 | Healthcare | 21.18% |
| 2 | Energy | 17.33% |
| 3 | Communication Services | 15.59% |
| 4 | Technology | 7.88% |
| 5 | Industrials | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SN
26
DELISTED
Sanchez Energy Corporation
SN
| $1.83M | 0.83% |
+48,730
| New | +$1.83M |
|
|
UPI
27
DELISTED
UROPLASTY INC-NEW
UPI
| $1.55M | 0.7% |
579,112
+181,799
| +46% | +$487K |
|
|
ATTU
28
DELISTED
Attunity Ltd
ATTU
| $1.44M | 0.65% |
185,500
| – | – |
|
|
DWCH
29
DELISTED
Datawatch Corp
DWCH
| $678K | 0.31% |
45,310
| – | – |
|
30
Exxon Mobil
XOM
$477B
| $572K | 0.26% |
5,685
| – | – |
|
|
RHT
31
DELISTED
Red Hat Inc
RHT
| $440K | 0.2% |
7,966
| – | – |
|
32
Home Depot
HD
$406B
| $413K | 0.19% |
5,100
| – | – |
|
|
CUTR
33
DELISTED
Cutera, Inc.
CUTR
| $375K | 0.17% |
36,050
| – | – |
|
|
EXXI
34
DELISTED
ENERGY XXI LTD COM SHS
EXXI
| $354K | 0.16% |
15,000
| – | – |
|
35
Norfolk Southern
NSC
$62.4B
| $281K | 0.13% |
2,729
| – | – |
|
36
Chevron
CVX
$318B
| $238K | 0.11% |
1,821
| – | – |
|
37
Quest Diagnostics
DGX
$20.1B
| $221K | 0.1% |
3,764
| – | – |
|
38
Johnson & Johnson
JNJ
$429B
| $218K | 0.1% |
2,086
| – | – |
|
39
Procter & Gamble
PG
$370B
| $214K | 0.1% |
2,723
| – | – |
|
40
Alnylam Pharmaceuticals
ALNY
$58.6B
| $208K | 0.09% |
3,300
+300
| +10% | +$18.9K |
|
41
Gilead Sciences
GILD
$140B
| – | – |
0
| – | – |
|